Skip to content

Thyroid Autotransplantation in Quadriceps Femoris Muscle

Implantation of Thyroid Gland After Total Thyroidectomy in Quadriceps Femoris Muscle

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04684953
Enrollment
40
Registered
2020-12-28
Start date
2022-01-31
Completion date
2022-12-31
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid

Brief summary

providing an almost natural ectopic thyroid in patients undergoing total thyroidectomy, remains a challenging subject that can benefits patients with a non-pharmacological substitute for their normal gland. this study seeks to prove that thyroid autotransplantation is possible and reliable.

Detailed description

Total thyroidectomy, rather thyroidectomy, is currently widely accepted as the modality of choice for treatment of benign thyroid disorders that require surgical excision. The goal of post-thyroidectomy management is to reach a safe physiological status of thyroid hormonal profile. Although exogenous levothyroxine replacement has long been safely used as a replacement after total thyroidectomy, it is not considered optimal, as it is bounded by patient's compliance with the treatment and follow-up schedule, effect of mal-absorption, and the inability to compensate for daily physiological alterations. The concept of endocrinal tissue auto-transplantation has been largely investigated in the case of parathyroid gland, and to a lesser extent for pancreatic islets. Although both the experimental studies of thyroid autotransplantation and the early case reports of lingual thyroid autotransplantations have shown encouraging results, a very limited number of clinical studies investigated thyroid autotransplantation in adult patients with benign thyroid disorders. Moreover, the discrepancy in the patients' characteristics and thyroid autotransplantation technique in these studies hinders the standardization of thyroid autotransplantation for clinical practice. Hypothetically, thyroid autotransplantation offers and attractive alternative for subtotal thyroidectomy, as it enables the preservation of native responsive thyroid tissue in an accessible location, and, thus, evades the risk of possible regrowth in the neck region. The present preliminary clinical study is conducted to investigate the feasibility and outcome of thyroid autotransplantation after total thyroidectomy for patients with benign thyroid disorders (other than thyroiditis).

Interventions

PROCEDUREThroid autotransplantation

Operative

thyroid hormone replacement therapy

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* adult male or female with simple nodular goitre. * patients who are fit for surgery.

Exclusion criteria

* children (male or female) * patients with malignant or recurrent goitre * patients who are unfit for surgery

Design outcomes

Primary

MeasureTime frame
normal level of thyroid hormone, and thyroid stimulating hormoneOne year

Contacts

Primary ContactMohamed A Hassan
mouhmed.ahmed@gmail.com01023858185
Backup ContactAbdullah Badawy, professor
badawy@aun.edu.eg01001861127

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026